These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10848006)

  • 21. CFSAN's program priorities: from food safety to food security.
    Levitt JA
    Food Drug Law J; 2003; 58(1):19-24. PubMed ID: 12739581
    [No Abstract]   [Full Text] [Related]  

  • 22. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 23. The FDA and product recalls.
    Meadows M
    FDA Consum; 2006; 40(3):30-5. PubMed ID: 16906665
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 25. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 28. Food for thought.
    Stipp D
    Fortune; 2003 Jul; 148(2):38, 40. PubMed ID: 12884674
    [No Abstract]   [Full Text] [Related]  

  • 29. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
    Foote JC
    J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The problem with the double-edged solution.
    Czap A
    Altern Med Rev; 2009 Jun; 14(2):96-8. PubMed ID: 19594219
    [No Abstract]   [Full Text] [Related]  

  • 31. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 32. Congress strengthens pet food safety regulations.
    Nolen RS
    J Am Vet Med Assoc; 2007 Nov; 231(9):1320-1. PubMed ID: 17975986
    [No Abstract]   [Full Text] [Related]  

  • 33. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV drugs. New Congress could create hurdles for drug patents.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014
    [No Abstract]   [Full Text] [Related]  

  • 35. Putting all your eggs in one basket: egg safety and the case for a single food-safety agency.
    Eskin SB
    Food Drug Law J; 2004; 59(3):441-52. PubMed ID: 15586995
    [No Abstract]   [Full Text] [Related]  

  • 36. Are we cutting the GRAS? Food safety perceptions are diminished by dysfunctional bureaucratic silos.
    O'Reilly JT
    Food Drug Law J; 2004; 59(3):417-26. PubMed ID: 15586991
    [No Abstract]   [Full Text] [Related]  

  • 37. What are some of the major changes in the 2005 Food Code?
    Marcason W
    J Am Diet Assoc; 2006 Feb; 106(2):317. PubMed ID: 16442882
    [No Abstract]   [Full Text] [Related]  

  • 38. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 39. Food safety inspections: a call for rational reorganization.
    DeWaal CS
    Food Drug Law J; 1999; 54(3):453-8. PubMed ID: 11797708
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.